Olema Pharmaceuticals, Inc. Collaboration Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Drug Discovery Collaboration and License Agreement between Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Amendment No. 1 to Drug Discovery Collaboration and License Agreement between Olema Pharmaceuticals, Inc. and Aurigene Oncology Limited
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Clinical Trial Collaboration and Supply Agreement between Olema Pharmaceuticals, Inc. and Novartis Pharma AG (Phase III Study of OP-1250 and Ribociclib)
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2025
Amendment No. 2 to Amended and Restated Clinical Collaboration and Supply Agreement between Olema Pharmaceuticals, Inc. and Novartis Institutes for BioMedical Research, Inc.
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2024
Amendment No. 1 to Amended and Restated Clinical Collaboration and Supply Agreement between Olema Pharmaceuticals, Inc. and Novartis Institutes for BioMedical Research, Inc.
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2023
Amended and Restated Clinical Collaboration and Supply Agreement between Olema Pharmaceuticals, Inc. and Novartis Institutes for BioMedical Research, Inc.
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2023
Drug Discovery Collaboration and License Agreement between Olema Pharmaceuticals, Inc. and Aurigene Discovery Technologies Limited (June 7, 2022)
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2022
Clinical Collaboration and Supply Agreement between Olema Pharmaceuticals, Inc. and Novartis Institutes for BioMedical Research, Inc.
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2020